The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global NAD+ Health Products Market Research Report 2024
Synopsis
NAD+ supplements are dietary supplements that contain compounds or precursors that can help increase the levels of nicotinamide adenine dinucleotide (NAD+) in the body. NAD+ is a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and cellular signaling.
The global NAD+ Health Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for NAD+ Health Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NAD+ Health Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of NAD+ Health Products include GeneHarbor, Chromadex, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL and Bontac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NAD+ Health Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NAD+ Health Products.
Report Scope
The NAD+ Health Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NAD+ Health Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NAD+ Health Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Chromadex
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Herbalmax
EffePharm
Kingdomway
NOMON Co., Ltd. (Teijin)
CELFULL
Bontac
Genex Formulas
EZZ
Maac10 Formulas
Elysium Health
Segment by Type
NMNContent ＜98%
NMNContent ≥98%
Segment by Application
Health Care Products
Beauty Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NAD+ Health Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NAD+ Health Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
NAD+ supplements are dietary supplements that contain compounds or precursors that can help increase the levels of nicotinamide adenine dinucleotide (NAD+) in the body. NAD+ is a coenzyme that plays a crucial role in various cellular processes, including energy metabolism, DNA repair, and cellular signaling.
The global NAD+ Health Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for NAD+ Health Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NAD+ Health Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of NAD+ Health Products include GeneHarbor, Chromadex, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL and Bontac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NAD+ Health Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NAD+ Health Products.
Report Scope
The NAD+ Health Products market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NAD+ Health Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NAD+ Health Products manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Chromadex
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Herbalmax
EffePharm
Kingdomway
NOMON Co., Ltd. (Teijin)
CELFULL
Bontac
Genex Formulas
EZZ
Maac10 Formulas
Elysium Health
Segment by Type
NMNContent ＜98%
NMNContent ≥98%
Segment by Application
Health Care Products
Beauty Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of NAD+ Health Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of NAD+ Health Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 NAD+ Health Products Market Overview
1.1 Product Overview and Scope of NAD+ Health Products
1.2 NAD+ Health Products Segment by Type
1.2.1 Global NAD+ Health Products Market Value Comparison by Type (2024-2030)
1.2.2 NMNContent ＜98%
1.2.3 NMNContent ≥98%
1.3 NAD+ Health Products Segment by Application
1.3.1 Global NAD+ Health Products Market Value by Application: (2024-2030)
1.3.2 Health Care Products
1.3.3 Beauty Products
1.3.4 Others
1.4 Global NAD+ Health Products Market Size Estimates and Forecasts
1.4.1 Global NAD+ Health Products Revenue 2019-2030
1.4.2 Global NAD+ Health Products Sales 2019-2030
1.4.3 Global NAD+ Health Products Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 NAD+ Health Products Market Competition by Manufacturers
2.1 Global NAD+ Health Products Sales Market Share by Manufacturers (2019-2024)
2.2 Global NAD+ Health Products Revenue Market Share by Manufacturers (2019-2024)
2.3 Global NAD+ Health Products Average Price by Manufacturers (2019-2024)
2.4 Global NAD+ Health Products Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of NAD+ Health Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NAD+ Health Products, Product Type & Application
2.7 NAD+ Health Products Market Competitive Situation and Trends
2.7.1 NAD+ Health Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NAD+ Health Products Players Market Share by Revenue
2.7.3 Global NAD+ Health Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NAD+ Health Products Retrospective Market Scenario by Region
3.1 Global NAD+ Health Products Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global NAD+ Health Products Global NAD+ Health Products Sales by Region: 2019-2030
3.2.1 Global NAD+ Health Products Sales by Region: 2019-2024
3.2.2 Global NAD+ Health Products Sales by Region: 2025-2030
3.3 Global NAD+ Health Products Global NAD+ Health Products Revenue by Region: 2019-2030
3.3.1 Global NAD+ Health Products Revenue by Region: 2019-2024
3.3.2 Global NAD+ Health Products Revenue by Region: 2025-2030
3.4 North America NAD+ Health Products Market Facts & Figures by Country
3.4.1 North America NAD+ Health Products Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America NAD+ Health Products Sales by Country (2019-2030)
3.4.3 North America NAD+ Health Products Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe NAD+ Health Products Market Facts & Figures by Country
3.5.1 Europe NAD+ Health Products Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe NAD+ Health Products Sales by Country (2019-2030)
3.5.3 Europe NAD+ Health Products Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NAD+ Health Products Market Facts & Figures by Country
3.6.1 Asia Pacific NAD+ Health Products Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific NAD+ Health Products Sales by Country (2019-2030)
3.6.3 Asia Pacific NAD+ Health Products Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NAD+ Health Products Market Facts & Figures by Country
3.7.1 Latin America NAD+ Health Products Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America NAD+ Health Products Sales by Country (2019-2030)
3.7.3 Latin America NAD+ Health Products Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NAD+ Health Products Market Facts & Figures by Country
3.8.1 Middle East and Africa NAD+ Health Products Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa NAD+ Health Products Sales by Country (2019-2030)
3.8.3 Middle East and Africa NAD+ Health Products Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NAD+ Health Products Sales by Type (2019-2030)
4.1.1 Global NAD+ Health Products Sales by Type (2019-2024)
4.1.2 Global NAD+ Health Products Sales by Type (2025-2030)
4.1.3 Global NAD+ Health Products Sales Market Share by Type (2019-2030)
4.2 Global NAD+ Health Products Revenue by Type (2019-2030)
4.2.1 Global NAD+ Health Products Revenue by Type (2019-2024)
4.2.2 Global NAD+ Health Products Revenue by Type (2025-2030)
4.2.3 Global NAD+ Health Products Revenue Market Share by Type (2019-2030)
4.3 Global NAD+ Health Products Price by Type (2019-2030)
5 Segment by Application
5.1 Global NAD+ Health Products Sales by Application (2019-2030)
5.1.1 Global NAD+ Health Products Sales by Application (2019-2024)
5.1.2 Global NAD+ Health Products Sales by Application (2025-2030)
5.1.3 Global NAD+ Health Products Sales Market Share by Application (2019-2030)
5.2 Global NAD+ Health Products Revenue by Application (2019-2030)
5.2.1 Global NAD+ Health Products Revenue by Application (2019-2024)
5.2.2 Global NAD+ Health Products Revenue by Application (2025-2030)
5.2.3 Global NAD+ Health Products Revenue Market Share by Application (2019-2030)
5.3 Global NAD+ Health Products Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GeneHarbor
6.1.1 GeneHarbor Corporation Information
6.1.2 GeneHarbor Description and Business Overview
6.1.3 GeneHarbor NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GeneHarbor NAD+ Health Products Product Portfolio
6.1.5 GeneHarbor Recent Developments/Updates
6.2 Chromadex
6.2.1 Chromadex Corporation Information
6.2.2 Chromadex Description and Business Overview
6.2.3 Chromadex NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chromadex NAD+ Health Products Product Portfolio
6.2.5 Chromadex Recent Developments/Updates
6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
6.3.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Corporation Information
6.3.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Business Overview
6.3.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Health Products Product Portfolio
6.3.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments/Updates
6.4 Herbalmax
6.4.1 Herbalmax Corporation Information
6.4.2 Herbalmax Description and Business Overview
6.4.3 Herbalmax NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Herbalmax NAD+ Health Products Product Portfolio
6.4.5 Herbalmax Recent Developments/Updates
6.5 EffePharm
6.5.1 EffePharm Corporation Information
6.5.2 EffePharm Description and Business Overview
6.5.3 EffePharm NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.5.4 EffePharm NAD+ Health Products Product Portfolio
6.5.5 EffePharm Recent Developments/Updates
6.6 Kingdomway
6.6.1 Kingdomway Corporation Information
6.6.2 Kingdomway Description and Business Overview
6.6.3 Kingdomway NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kingdomway NAD+ Health Products Product Portfolio
6.6.5 Kingdomway Recent Developments/Updates
6.7 NOMON Co., Ltd. (Teijin)
6.6.1 NOMON Co., Ltd. (Teijin) Corporation Information
6.6.2 NOMON Co., Ltd. (Teijin) Description and Business Overview
6.6.3 NOMON Co., Ltd. (Teijin) NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NOMON Co., Ltd. (Teijin) NAD+ Health Products Product Portfolio
6.7.5 NOMON Co., Ltd. (Teijin) Recent Developments/Updates
6.8 CELFULL
6.8.1 CELFULL Corporation Information
6.8.2 CELFULL Description and Business Overview
6.8.3 CELFULL NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CELFULL NAD+ Health Products Product Portfolio
6.8.5 CELFULL Recent Developments/Updates
6.9 Bontac
6.9.1 Bontac Corporation Information
6.9.2 Bontac Description and Business Overview
6.9.3 Bontac NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bontac NAD+ Health Products Product Portfolio
6.9.5 Bontac Recent Developments/Updates
6.10 Genex Formulas
6.10.1 Genex Formulas Corporation Information
6.10.2 Genex Formulas Description and Business Overview
6.10.3 Genex Formulas NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Genex Formulas NAD+ Health Products Product Portfolio
6.10.5 Genex Formulas Recent Developments/Updates
6.11 EZZ
6.11.1 EZZ Corporation Information
6.11.2 EZZ NAD+ Health Products Description and Business Overview
6.11.3 EZZ NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.11.4 EZZ NAD+ Health Products Product Portfolio
6.11.5 EZZ Recent Developments/Updates
6.12 Maac10 Formulas
6.12.1 Maac10 Formulas Corporation Information
6.12.2 Maac10 Formulas NAD+ Health Products Description and Business Overview
6.12.3 Maac10 Formulas NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Maac10 Formulas NAD+ Health Products Product Portfolio
6.12.5 Maac10 Formulas Recent Developments/Updates
6.13 Elysium Health
6.13.1 Elysium Health Corporation Information
6.13.2 Elysium Health NAD+ Health Products Description and Business Overview
6.13.3 Elysium Health NAD+ Health Products Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Elysium Health NAD+ Health Products Product Portfolio
6.13.5 Elysium Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NAD+ Health Products Industry Chain Analysis
7.2 NAD+ Health Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NAD+ Health Products Production Mode & Process
7.4 NAD+ Health Products Sales and Marketing
7.4.1 NAD+ Health Products Sales Channels
7.4.2 NAD+ Health Products Distributors
7.5 NAD+ Health Products Customers
8 NAD+ Health Products Market Dynamics
8.1 NAD+ Health Products Industry Trends
8.2 NAD+ Health Products Market Drivers
8.3 NAD+ Health Products Market Challenges
8.4 NAD+ Health Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
